Skip to main content

$0.042 -0.001 (-2.33%)

High

$0.04

Low

$0.04

Trades

17

Turnover

$24,861

Volume

582,113
30 June 2023 at 3:56pm
Register to track ACR and receive email alerts.
Subject
ACR Ann: Acrux Receives FDA Approval - Generic Efinaconazole Solution

ACR Ann: Notification of cessation of securities - ACR

ACR Ann: Change in Company Secretary

ACR Ann: Change of Director's Interest Notice - Ross Dobinson

ACR Ann: Application for quotation of securities - ACR

ACR Ann: Acrux confirms patent challenge

ACR Ann: Final Director's Interest Notice - amended

ACR Ann: Final Director's Interest Notice - Mr Norman Gray

ACR Ann: Initial Director's Interest Notice - Mr Don Brumley

ACR Ann: Acrux Limited Announces Board Appointment

ACR Ann: R&D Tax Incentive Rebate - Overseas Finding Application

ACR Ann: Appendix 2A

ACR Ann: R&D Tax Incentive Rebate - Overseas Finding Application

ACR Ann: Appendix 2A

ACR Ann: Acrux's fourth generic dossier accepted by FDA for review

ACR Ann: Change of Director's Interest Notice - Ross Dobinson

ACR Ann: Appendix 2A

ACR Ann: Acrux Investor Presentation

ACR Ann: Appendix 4D and Half Year Accounts - for the 31 Dec ac

ACR Ann: Appendix 2A

ACR Ann: Amended Appendix 3Y - Geoff Brooke

ACR Ann: Appendix 2A

ACR Ann: Appendix 3G

ACR Ann: Change of Director's Interest Notice

ACR Ann: Cleansing Statement

ACR Ann: Appendix 2A

ACR Ann: Appendix 2A - Share Purchase Plan

ACR Ann: Share Purchase Plan Closes Oversubscribed

ACR Ann: Results of Extraordinary General Meeting

ACR Ann: Change of Director's Interest Notice

ACR Ann: Appendix 2A

ACR Ann: Acrux Receives FDA Approval - Generic Testosterone Solution

ACR Ann: Acrux Ltd Share Purchase Plan Offer Booklet

ACR Ann: Ceasing to be a substantial holder

ACR Ann: Ceasing to be a substantial holder

ACR Ann: Becoming a substantial holder

ACR Ann: Cleansing Notice

ACR Ann: EGM - Virtual Meeting Online Guide

ACR Ann: Notice of Extraordinary General Meeting/Proxy Form

ACR Ann: Appendix 2A

ACR Ann: Proposed issue of Securities - ACR

ACR Ann: Proposed issue of Securities - ACR

ACR Ann: Acrux Raises $7.8m Via Placement and Announces SPP

ACR Ann: Trading Halt

ACR Ann: Change of Director's Interest Notice

ACR Ann: Appendix 2A

ACR Ann: Change of Director's Interest Notice

ACR Ann: Appendix 3G

ACR Ann: Results of Annual General Meeting

ACR Ann: Annual General Meeting Script

Register to track ACR and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL